Rhox4 inhibitors are a class of chemical compounds designed to specifically target and modulate the activity of the Rhox4 protein, a member of the reproductive homeobox (Rhox) gene family. Rhox4 is a transcription factor that plays a key role in regulating gene expression within reproductive tissues, such as the testes and ovaries. This protein is involved in critical processes including spermatogenesis, folliculogenesis, and the overall development and maintenance of reproductive organs. By binding to specific DNA sequences, Rhox4 controls the transcription of various genes that are essential for the proper functioning of reproductive cells. Inhibitors of Rhox4 are developed to interfere with its DNA-binding capability or to disrupt its interaction with other transcriptional machinery components. This disruption allows researchers to investigate the specific functions of Rhox4 in reproductive biology and to understand its role in the complex network of gene regulation.
The development of Rhox4 inhibitors involves a detailed understanding of the protein's structure and its interactions with DNA and other proteins. Structural biology techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to elucidate the three-dimensional configuration of Rhox4. This structural insight is crucial for identifying the protein's DNA-binding domain and other regions that are essential for its function as a transcription factor. Computational methods, including molecular docking and virtual screening, are then used to identify small molecules that can bind to these critical regions, effectively inhibiting Rhox4's activity. Once potential inhibitors are identified, they are synthesized and tested in vitro to evaluate their binding affinity, specificity, and inhibitory potency. Through iterative cycles of chemical refinement and testing, these inhibitors are optimized to enhance their effectiveness and selectivity. The study of Rhox4 inhibitors not only provides valuable tools for understanding the role of this transcription factor in reproductive processes but also contributes to a broader understanding of the molecular mechanisms that govern gene expression and regulation in reproductive tissues, shedding light on the intricate processes that underlie fertility and reproductive health.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid receptor agonist, can modulate immune response and stress pathways, potentially influencing Rhox4-related processes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, can alter gene expression patterns, potentially impacting Rhox4 expression or function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, can change chromatin structure and gene expression, possibly affecting Rhox4. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor, similar to Trichostatin A, could influence Rhox4 expression by altering chromatin accessibility. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Estrogen receptor modulator, can affect hormone signaling pathways that might intersect with Rhox4's regulatory or functional pathways. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
Androgen receptor antagonist, could modulate signaling pathways potentially relevant to Rhox4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, affecting cell growth, proliferation, and differentiation pathways that Rhox4 may be involved in. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
Androgen receptor antagonist, potentially affecting androgen signaling pathways related to Rhox4. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
Aromatase inhibitor, can reduce estrogen synthesis, potentially influencing Rhox4's activity indirectly through hormonal pathways. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR tyrosine kinase inhibitor, could modulate signaling pathways potentially relevant to Rhox4's role in cellular signaling. | ||||||